The Epidemiology of Prostate Cancer

por Pernar, Claire H., Ebot, Ericka M., Wilson, Kathryn M., Mucci, Lorelei A.
Publicado en Cold Spring Harb Perspect Med (2018)

“CHALLENGE Trial 1 Year Feasibility Results”

por Pernar, Claire H., Markt, Sarah C., McKay, Rana R., Mucci, Lorelei A.
Publicado en Cancer Epidemiol Biomarkers Prev (2016)

Prostate cancer incidence as an iceberg

por Mucci, Lorelei A., Pernar, Claire H., Peisch, Sam, Gerke, Travis, Wilson, Kathryn M.
Publicado en Eur J Epidemiol (2017)

Guideline-Based Physical Activity and Survival Among US Men With Nonmetastatic Prostate Cancer

por Dickerman, Barbra A, Giovannucci, Edward, Pernar, Claire H, Mucci, Lorelei A, Hernán, Miguel A
Publicado en Am J Epidemiol (2019)

Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation

por Kensler, Kevin H, Pernar, Claire H, Mahal, Brandon A, Nguyen, Paul L, Trinh, Quoc-Dien, Kibel, Adam S, Rebbeck, Timothy R
Publicado en J Natl Cancer Inst (2020)

The association between neighborhood greenness and incidence of lethal prostate cancer: A prospective cohort study

por Iyer, Hari S., James, Peter, Valeri, Linda, Hart, Jaime E., Pernar, Claire H., Mucci, Lorelei A., Holmes, Michelle D., Laden, Francine, Rebbeck, Timothy R.
Publicado en Environ Epidemiol (2020)

A walking intervention among men with prostate cancer: a pilot study

por Pernar, Claire H., Fall, Katja, Rider, Jennifer R., Markt, Sarah C., Adami, Hans-Olov, Andersson, Sven-Olof, Valdimarsdottir, Unnur, Andrén, Ove, Mucci, Lorelei A.
Publicado en Clin Genitourin Cancer (2017)

IS THIS A PORTRAIT OF JOHN GRAUNT? AN ART HISTORY MYSTERY

por Murray, Eleanor J, Farland, Leslie V, Caniglia, Ellen C, Dorans, Kirsten S, DuPre, Natalie C, Hughes, Katherine C, Kim, Iris Y, Pernar, Claire H, Tanz, Lauren J, Zack, Rachel M
Publicado en Am J Epidemiol (2019)

Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer

por Pernar, Claire H., Parmigiani, Giovanni, Giovannucci, Edward L., Rimm, Eric B., Tyekucheva, Svitlana, Loda, Massimo, Finn, Stephen P., Vander Heiden, Matthew G., Fiorentino, Michelangelo, Ebot, Ericka M., Mucci, Lorelei A.
Publicado en Cancer Epidemiol Biomarkers Prev (2021)

Baldness and Risk of Prostate Cancer in the Health Professionals Follow-Up Study

por Khan, Saud, Caldwell, Joshua, Wilson, Kathryn M., Gonzalez-Feliciano, Amparo G., Peisch, Sam, Pernar, Claire H., Graff, Rebecca E., Giovannucci, Edward L., Mucci, Lorelei A., Gerke, Travis A., Markt, Sarah C.
Publicado en Cancer Epidemiol Biomarkers Prev (2020)

Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer

por Fu, Benjamin C., Tabung, Fred K., Pernar, Claire H., Wang, Weike, Gonzalez-Feliciano, Amparo G., Chowdhury-Paulino, Ilkania M., Clinton, Steven K., Folefac, Edmund, Song, Mingyang, Kibel, Adam S., Giovannucci, Edward L., Mucci, Lorelei A.
Publicado en Eur Urol (2021)

A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study

por Dickerman, Barbra A., Ebot, Ericka M., Healy, Brian C., Wilson, Kathryn M., Eliassen, A. Heather, Ascherio, Alberto, Pernar, Claire H., Zeleznik, Oana A., Vander Heiden, Matthew G., Clish, Clary B., Giovannucci, Edward, Mucci, Lorelei A.
Publicado en Metabolites (2020)

The association of diabetes with risk of prostate cancer defined by clinical and molecular features

por Feng, Xiaoshuang, Song, Mingyang, Preston, Mark A., Ma, Wenjie, Hu, Yang, Pernar, Claire H., Stopsack, Konrad H., Ebot, Ericka M., Fu, Benjamin C., Zhang, Yiwen, Li, Ni, Dai, Min, Liu, Lydia, Giovannucci, Edward L., Mucci, Lorelei A.
Publicado en Br J Cancer (2020)

A prospective study of aspirin use and prostate cancer risk by TMPRSS2:ERG status

por Stopsack, Konrad H., Gonzalez-Feliciano, Amparo G., Peisch, Samuel F., Downer, Mary K., Gage, Riley A., Finn, Stephen, Lis, Rosina T., Graff, Rebecca E., Pettersson, Andreas, Pernar, Claire H., Loda, Massimo, Kantoff, Philip W., Ahearn, Thomas U., Mucci, Lorelei A.
Publicado en Cancer Epidemiol Biomarkers Prev (2018)

Association of pre-diagnostic blood metabolomics with prostate cancer defined by ERG or PTEN molecular subtypes

por Feng, Xiaoshuang, Zhou, Cindy Ke., Clish, Clary B., Wilson, Kathryn M., Pernar, Claire H., Dickerman, Barbra A., Loda, Massimo, Finn, Stephen P., Penney, Kathryn L., Schmidt, Daniel R., Vander Heiden, Matthew G., Giovannucci, Edward L., Ebot, Ericka M., Mucci, Lorelei A.
Publicado en Cancer Epidemiol Biomarkers Prev (2021)

Family history of prostate cancer and the incidence of ERG- and PTEN-defined prostate cancer

por Hashim, Dana, Gonzalez-Feliciano, Amparo G., Ahearn, Thomas U., Pettersson, Andreas, Barber, Lauren, Pernar, Claire H., Ebot, Ericka M., Isikbay, Masis, Finn, Stephen P., Giovannucci, Edward L., Lis, Rosina T., Loda, Massimo, Parmigiani, Giovanni, Lotan, Tamara, Kantoff, Philip W., Mucci, Lorelei A., Graff, Rebecca E.
Publicado en Int J Cancer (2019)

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG

por Pernar, Claire H., Ebot, Ericka M., Pettersson, Andreas, Graff, Rebecca E., Giunchi, Francesca, Ahearn, Thomas U., Gonzalez-Feliciano, Amparo G., Markt, Sarah C., Wilson, Kathryn M., Stopsack, Konrad H., Gazeeva, Elizaveta, Lis, Rosina T., Parmigiani, Giovanni, Rimm, Eric B., Finn, Stephen P., Giovannucci, Edward L., Fiorentino, Michelangelo, Mucci, Lorelei A.
Publicado en Eur Urol (2018)

Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer

por Graff, Rebecca E., Ahearn, Thomas U., Pettersson, Andreas, Ebot, Ericka M., Gerke, Travis, Penney, Kathryn L., Wilson, Kathryn M., Markt, Sarah C., Pernar, Claire H., Gonzalez-Feliciano, Amparo G., Song, Mingyang, Lis, Rosina T., Schmidt, Daniel R., Vander Heiden, Matthew G., Fiorentino, Michelangelo, Giovannucci, Edward L., Loda, Massimo, Mucci, Lorelei A.
Publicado en Cancer Epidemiol Biomarkers Prev (2017)

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of...

por Watts, Eleanor L., Perez‐Cornago, Aurora, Appleby, Paul N., Albanes, Demetrius, Ardanaz, Eva, Black, Amanda, Bueno‐de‐Mesquita, H. Bas, Chan, June M., Chen, Chu, Chubb, S.A. Paul, Cook, Michael B., Deschasaux, Mélanie, Donovan, Jenny L., English, Dallas R., Flicker, Leon, Freedman, Neal D., Galan, Pilar, Giles, Graham G., Giovannucci, Edward L., Gunter, Marc J., Habel, Laurel A., Häggström, Christel, Haiman, Christopher, Hamdy, Freddie C., Hercberg, Serge, Holly, Jeff M., Huang, Jiaqi, Huang, Wen‐Yi, Johansson, Mattias, Kaaks, Rudolf, Kubo, Tatsuhiko, Lane, J. Athene, Layne, Tracy M., Le Marchand, Loic, Martin, Richard M., Metter, E. Jeffrey, Mikami, Kazuya, Milne, Roger L., Morris, Howard A., Mucci, Lorelei A., Neal, David E., Neuhouser, Marian L., Oliver, Steven E., Overvad, Kim, Ozasa, Kotaro, Pala, Valeria, Pernar, Claire H., Pollak, Michael, Rowlands, Mari‐Anne, Schaefer, Catherine A., Schenk, Jeannette M., Stattin, Pär, Tamakoshi, Akiko, Thysell, Elin, Touvier, Mathilde, Trichopoulou, Antonia, Tsilidis, Konstantinos K., Van Den Eeden, Stephen K., Weinstein, Stephanie J., Wilkens, Lynne, Yeap, Bu B., Key, Timothy J., Allen, Naomi E., Travis, Ruth C.
Publicado en Int J Cancer (2019)